Claudio Botti

Istituti di Ricovero e Cura a Carattere Scientifico — Italy

Biochemistry, Genetics and Molecular Biology · Life Sciences

38h-index4.7kcitations221works4.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Breast Cancer Treatment Studies(49), Cancer Treatment and Pharmacology(27), HER2/EGFR in Cancer Research(25), Cancer Cells and Metastasis(15), Monoclonal and Polyclonal Antibodies Research(15)

Publications221 total

PROTAC-mediated degradation of Bcl-xL potentiates target therapy in preclinical melanoma models
Journal of Experimental & Clinical Cancer Research·2026· 1 citedOpen Access
Multimodal deep learning for predicting neoadjuvant treatment outcomes in breast cancer: a systematic review
Biology Direct·2025· 5 citedOpen Access
Six-Year Results From a Prospective Phase 2 Trial of 10-Fraction Hypofractionated Radiation Therapy in Locally Advanced Breast Cancer
Practical Radiation Oncology·2025
CircPVT1 weakens miR-33a-5p unleashing the c-MYC/GLS1 metabolic axis in breast cancer
Journal of Experimental & Clinical Cancer Research·2025· 11 citedOpen Access
Prognostic value of lymph node ratio (LNR) and log odds of positive lymph nodes (LODDS) in patients with locally advanced triple-negative breast cancer: An oncological-high flow center experience
Il Giornale di Chirurgia - Journal of the Italian Association of Hospital Surgeons·2025Open Access
Preoperative Magnetic Seed Versus Wire‐Guided Localization in the Treatment of Nonpalpable Breast Cancer: A Retrospective Observational Study at a Tertiary Care Center
International Journal of Breast Cancer·2025· 1 citedOpen Access
Tolerability and Preliminary Outcomes of Adjuvant T-DM1 in HER2-Positive Breast Cancer After Neoadjuvant Therapy: The ATD Study
Cancers·2024· 2 citedOpen Access
Comparison of Indocyanine Green with conventional tracers for sentinel lymph node biopsy in breast cancer: A multidisciplinary evaluation of clinical effectiveness, safety, organizational and economic impact
PLoS ONE·2024· 12 citedOpen Access
DNA Damage Response in Early Breast Cancer: A Phase III Cohort in the Phobos Study
Cancers·2024Open Access
CircPVT1 sponges miR-33a-5p unleashing the c-MYC/GLS1 metabolic axis in breast cancer
2024Open Access
Bcl-2 dependent modulation of Hippo pathway in cancer cells
Cell Communication and Signaling·2024· 11 citedOpen Access
<i>HER2</i> mutation as an emerging target in advanced breast cancer
Cancer Science·2024· 9 citedOpen Access
Breast and cervical cancer in transgender men: literature review and a case report
Therapeutic Advances in Medical Oncology·2024· 9 citedOpen Access
HTA258 A Hospital-Based Health Technology Assessment of Near-Infrared Fluorescence Using Indocyanine Green for Sentinel Lymph Node Mapping for Breast Cancer and Gynecologic Cancer
Value in Health·2023Open Access
Regina Elena Institute (R.E.I.) Protocol for Breast Implant Salvage: Preliminary Results
Clinical Breast Cancer·2023· 4 cited
Exploiting Long Non-Coding RNAs and Circular RNAs as Pharmacological Targets in Triple-Negative Breast Cancer Treatment
Cancers·2023· 11 citedOpen Access
Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from CaRe, a multicentric, observational study
Frontiers in Oncology·2023· 7 citedOpen Access
Sexual dysfunctions in breast cancer patients: evidence in context
Sexual Medicine Reviews·2023· 17 citedOpen Access
Supplementary Figure Legend from The Cytoskeleton Regulatory Protein hMena (ENAH) Is Overexpressed in Human Benign Breast Lesions with High Risk of Transformation and Human Epidermal Growth Factor Receptor-2–Positive/Hormonal Receptor–Negative Tumors
2023Open Access
Supplementary Figure 1 from The Cytoskeleton Regulatory Protein hMena (ENAH) Is Overexpressed in Human Benign Breast Lesions with High Risk of Transformation and Human Epidermal Growth Factor Receptor-2–Positive/Hormonal Receptor–Negative Tumors
2023Open Access
page 1 of 12Next →

Frequent Co-authors

Marcella Mottolese(17), Patrizia Vici(13), Franco Di Filippo(11), Diana Giannarelli(9), Piero Alò(7), Paolo Visca(7), Pier Giorgio Natali(7), Ugo Di Tondo(6), Valeria Sebastiani(5), Laura Pizzuti(5), Luigi Di Lauro(5), Maddalena Barba(5), C.L. Maini(5), Clara Natoli(4), Teresa Gamucci(4), F. Cognetti(4), Simonetta Buglioni(4), Paola Papaldo(4), Enrico Cortesi(4), Francesco Cavaliere(4)